Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study status is updated to Completed, and new dates/metadata were added (Study Completion Actual: 2023-04-26; latest updates: 2026-05-11 and 2026-05-13; Revision: v3.5.4).
    Difference
    0.5%
    Check dated 2026-05-14T23:07:04.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    - Revision: v3.5.3 supersedes v3.5.2, indicating a minor administrative update to the study record on ClinicalTrials.gov. - The update does not change any study details or user-visible content.
    Difference
    0.1%
    Check dated 2026-04-30T15:45:09.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2, replacing the previous v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:51.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added a Hepatocellular carcinoma tag and a link to the Genetic and Rare Diseases Information Center; updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T18:12:56.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:36:06.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added, and the government funding lapse notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:19:37.000Z thumbnail image

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.